Crowdonomics
WatchlistPortfolio
All companies
BioEclipse Therapeutics logo

BioEclipse Therapeutics

Operating

BioEclipse Therapeutics, Inc.

Software & AI · Founded 2006

Visit website

Clinical-stage oncology company that uses platform technology to develop immuno-oncology therapeutics

Post-money valuation ⓘ
$29.0M
As of Apr 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$10,126,014
Crowd $0 · Private $10.1M · 2 rounds since 2019
Latest share price
$2.55
Reg CF Offering (2022) offering price

Financials

FY2019–FY2020 · from SEC filings · hover any figure for its source
$0
−$2.4M
2019
$0
−$4.4M
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed
FY2020 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$2,415,736
-$4,391,188
Taxes paid
$0
$0
Balance sheet
Cash
$5,394,836
$2,331,499
Accounts receivable
$0
$0
Total assets
$5,839,337
$2,956,073
Short-term debt
$0
$75,862
Long-term debt
$0
$0
Total liabilities
$0
$75,862
Other
Headcount
—
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$29.0M
pre-money
Reg CF · Common · Jan 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Jan 2022Closedvia Netcapital
Raised $0 / $1.1MPost-money $29M
Rule 506(b) · Equity · Jun 2019Closed
Raised $10.1MInvestors 13

Team

4 people
Cathy Sohn
Board Member
Gregory Schiffman
Board Member
Mark Frohlich
Board Member
Pamela Contag
Principal Executive Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

13 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 1, 20220001669191-22-000335
    EDGAR
  • Form C/AFeb 28, 20220001669191-22-000203
    EDGAR
  • Form CJan 19, 20220001669191-22-000053
    EDGAR
  • Form D/AOct 10, 20190001780708-19-000004
    EDGAR
  • Form DJun 25, 20190001780708-19-000003
    EDGAR
Source: ManualCIK 0001780708Share price $2.55

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.